Royalty Pharma
RPRX
#1008
Rank
NZ$32.94 B
Marketcap
$57.15
Share price
-0.49%
Change (1 day)
17.41%
Change (1 year)

P/S ratio for Royalty Pharma (RPRX)

P/S ratio as of March 2025 (TTM): 8.34

According to Royalty Pharma's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.83. At the end of 2024 the company had a P/S ratio of 6.65.

P/S ratio history for Royalty Pharma from 2020 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20246.65-7.06%
20237.15-8.2%
20227.794.23%
20217.48-18.32%
20209.15

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
2.30-72.37%๐Ÿ‡บ๐Ÿ‡ธ USA
5.78-30.70%๐Ÿ‡บ๐Ÿ‡ธ USA
16.5 98.38%๐Ÿ‡บ๐Ÿ‡ธ USA